These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 26412717)
1. Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays. Bennour A; Saad A; Sennana H Crit Rev Oncol Hematol; 2016 Jan; 97():263-74. PubMed ID: 26412717 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Johansson B; Fioretos T; Mitelman F Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388 [TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment. Morris CM Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of clonal chromosomal abnormalities in Philadelphia negative cells in CML patients after treated with tyrosine kinase inhibitors. Ni H; Sun X; Xu Y; Lyle D; Petersen P; Zhao X; Drum H; You B; Liu D; Liu C; Jiang JG Cancer Genet; 2019 Oct; 238():44-49. PubMed ID: 31425925 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update. Molica M; Massaro F; Breccia M Expert Rev Mol Diagn; 2017 Nov; 17(11):1001-1008. PubMed ID: 28930482 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients. Jha CB; Kucheria K; Choudhary VP Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893 [TBL] [Abstract][Full Text] [Related]
7. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization]. Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of the Relationship between Cytogenetic Changes and Course Evolution of Patients with CML during TKI Treatment]. Wang K; Liu T; Dai J; Pang YX; Wang Q Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):136-140. PubMed ID: 32027266 [TBL] [Abstract][Full Text] [Related]
9. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression. Barbouti A; Johansson B; Höglund M; Mauritzson N; Strömbeck B; Nilsson PG; Tanke HJ; Hagemeijer A; Mitelman F; Fioretos T Genes Chromosomes Cancer; 2002 Oct; 35(2):127-37. PubMed ID: 12203776 [TBL] [Abstract][Full Text] [Related]
10. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia. Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867 [TBL] [Abstract][Full Text] [Related]
11. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia. Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions. Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983 [TBL] [Abstract][Full Text] [Related]
13. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651 [TBL] [Abstract][Full Text] [Related]
16. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589 [TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation. Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189 [TBL] [Abstract][Full Text] [Related]
18. Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. Tohami T; Nagler A; Amariglio N Isr Med Assoc J; 2012 Aug; 14(8):501-7. PubMed ID: 22977971 [TBL] [Abstract][Full Text] [Related]
19. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis. Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149 [TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemia in 2007. Sessions J Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S4-9. PubMed ID: 18056931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]